⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606391 | 1.00 | — | — | |
| SCHEMBL7496575 | 1.00 | — | — | |
| SCHEMBL1726593 | 1.00 | — | — | |
| SCHEMBL7496569 | 1.00 | — | — | |
| SCHEMBL64396 | 1.00 | — | — | |
| SCHEMBL1723503 | 1.00 | — | — | |
| SCHEMBL606385 | 1.00 | — | — | |
| SCHEMBL29208889 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3332500 | 0.98 | CCR5 (0.36) | — | |
| SCHEMBL8704625 | 0.93 | EPAS1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536658-B | Preparation method of moxifloxacin hydrochloride monohydrate | 天方药业有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-117230091-B | Imine reductase IR11 or mutant and application thereof | 四川大学华西第二医院 | 2024-01-19 | — | — | CN | claimed |
| CN-115322191-B | Synthetic method of moxifloxacin hydrochloride | 苏州汉德创宏生化科技有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-117230091-A | Imine reductase IR11 or mutant and application thereof | 四川大学华西第二医院 | 2023-12-15 | — | — | CN | claimed |
| WO-2022166436-A1 | METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE (S, S)-2, 8-DIAZABICYCLO [4, 3, 0] NONANE | 台州市生物医化产业研究院有限公司 | 2022-08-11 | — | — | WO | claimed |
| WO-2022166440-A1 | METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE, (S,S)-2,8-DIAZABICYCLO[4,3,0]NONANE | 台州市生物医化产业研究院有限公司 | 2022-08-11 | — | — | WO | claimed |
| EP-2089388-B1 | PROCESS FOR THE SYNTHESIS OF MOXIFLOXACIN HYDROCHLORIDE | CIPLA LTD (IN) | 2014-01-29 | — | — | EP | claimed |
| US-8198451-B2 | Process for the synthesis of moxifloxacin hydrochloride | CIPLA LIMITED (IN) | 2012-06-12 | — | — | US | claimed |
| US-20100152229-A1 | Process for the Synthesis of Moxifloxacin Hydrochloride | CIPLA LIMITED (IN) | 2010-06-17 | — | — | US | claimed |
| US-7692015-B2 | Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer | LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) | 2010-04-06 | — | — | US | claimed |
| EP-2121680-A1 | A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLOÝ4.3.0¨NONANE AND ITS ENANTIOMER | Wang, Zheqing (US) | 2009-11-25 | — | — | EP | claimed |
| US-20090259041-A1 | QUINOLINE CARBOXYLIC ACID-O,O BIS-ACYLOXY BORATE AND PROCESS OF MAKING | SATYANARAYANA CHAVA | 2009-10-15 | — | — | US | claimed |
| WO-2009125425-A2 | IMPROVED PROCESS FOR THE PREPARATION OF (S.S)-2.8-DIAZABICYCLO[4.3.0]NONANE | NEULAND LABORATORIES LTD (IN) | 2009-10-15 | — | — | WO | claimed |
| US-20080221329-A1 | Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer | LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) | 2008-09-11 | — | — | US | claimed |
| WO-2008085480-A1 | A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLO[4.3.0]NONANE AND ITS ENANTIOMER | WANG ZHEQING (US) | 2008-07-17 | — | — | WO | claimed |
| EP-1832587-A1 | Method for preparing moxifloxacin and moxifloxacin hydrochloride | Quimica Sintetica, S.A. (ES) | 2007-09-12 | — | — | EP | claimed |
| US-20060264635-A1 | Process for the preparation of moxifloxacin hydrochloride | MATRIX LABORATORIES LTD. (IN) | 2006-11-23 | — | — | US | claimed |
| EP-1077979-B1 | METHOD FOR PRODUCING (S,S)-BENZYL-2,8-DIAZABICYCLO 4.3.0]NONANE | BAYER HEALTHCARE AG (DE) | 2005-07-06 | — | — | EP | claimed |
| US-20040044205-A1 | Process for the enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane | LANXESS DEUTSCHLAND GMBH (DE) | 2004-03-04 | — | — | US | claimed |
| US-6235908-B1 | PREPARATION OF TARTRATE | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-22 | — | — | US | claimed |